blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1266005

EP1266005 - REGULATION OF HUMAN LIPOXIN A4 RECEPTOR-LIKE PROTEIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.01.2008
Database last updated on 05.10.2024
Most recent event   Tooltip11.09.2009Lapse of the patent in a contracting state
New state(s): TR		published on 14.10.2009  [2009/42]
Applicant(s)For all designated states
Bayer HealthCare AG
51368 Leverkusen / DE
[2007/10]
Former [2004/01]For all designated states
Bayer HealthCare AG
51368 Leverkusen / DE
Former [2002/51]For all designated states
Bayer Aktiengesellschaft
51368 Leverkusen / DE
Inventor(s)01 / RAMAKRISHNAN, Shyam
76 Euston Road, Apartment 10
Brighton, MA 02135 / US
 [2002/51]
Application number, filing date01925421.812.03.2001
[2002/51]
WO2001EP02729
Priority number, dateUS20000189037P14.03.2000         Original published format: US 189037 P
[2002/51]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0168839
Date:20.09.2001
Language:EN
[2001/38]
Type: A2 Application without search report 
No.:EP1266005
Date:18.12.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 20.09.2001 takes the place of the publication of the European patent application.
[2002/51]
Type: B1 Patent specification 
No.:EP1266005
Date:07.03.2007
Language:EN
[2007/10]
Search report(s)International search report - published on:EP28.03.2002
ClassificationIPC:C12N15/12, C07K14/72, C12N5/10, C12N1/21, C12Q1/68
[2006/38]
CPC:
G01N33/566 (EP,US); A61P37/08 (EP); A61P9/00 (EP);
C07K14/705 (EP,US); G01N33/88 (EP,US); A61K38/00 (EP,US);
G01N2333/726 (EP,US); G01N2500/10 (EP,US) (-)
Former IPC [2004/41]C12N15/12, C12N5/10, C12N1/21, C12Q1/68, C07K14/72, A61K38/17, G01N33/566
Former IPC [2002/51]C12N15/12, C07K14/705, C12N5/10, C12Q1/68, G01N33/53, A61K38/17, A61P9/00, A61P37/08
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/51]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:REGULATION DES MENSCHLICHES LIPOXIN A4 REZEPTOR-ÄHNLICHES PROTEIN[2002/51]
English:REGULATION OF HUMAN LIPOXIN A4 RECEPTOR-LIKE PROTEIN[2002/51]
French:REGULATION DE LA PROTEINE DE TYPE DU RECEPTEUR DE LA LIPOXINE A4 HUMAINE[2002/51]
Entry into regional phase14.10.2002National basic fee paid 
14.10.2002Designation fee(s) paid 
14.10.2002Examination fee paid 
Examination procedure10.09.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
14.10.2002Examination requested  [2002/51]
19.11.2003Despatch of a communication from the examining division (Time limit: M06)
13.04.2004Reply to a communication from the examining division
07.06.2004Despatch of a communication from the examining division (Time limit: M04)
02.10.2004Reply to a communication from the examining division
14.12.2004Despatch of a communication from the examining division (Time limit: M04)
25.02.2005Reply to a communication from the examining division
29.04.2005Despatch of a communication from the examining division (Time limit: M03)
10.06.2005Reply to a communication from the examining division
01.09.2005Despatch of a communication from the examining division (Time limit: M03)
27.10.2005Reply to a communication from the examining division
30.11.2005Despatch of a communication from the examining division (Time limit: M04)
04.04.2006Reply to a communication from the examining division
31.08.2006Communication of intention to grant the patent
10.01.2007Fee for grant paid
10.01.2007Fee for publishing/printing paid
Opposition(s)10.12.2007No opposition filed within time limit [2008/07]
Fees paidRenewal fee
31.03.2003Renewal fee patent year 03
31.03.2004Renewal fee patent year 04
31.03.2005Renewal fee patent year 05
31.03.2006Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT07.03.2007
BE07.03.2007
CY07.03.2007
DK07.03.2007
FI07.03.2007
NL07.03.2007
TR07.03.2007
IE12.03.2007
LU12.03.2007
MC31.03.2007
GR08.06.2007
PT07.08.2007
[2009/42]
Former [2009/37]AT07.03.2007
BE07.03.2007
CY07.03.2007
DK07.03.2007
FI07.03.2007
NL07.03.2007
IE12.03.2007
LU12.03.2007
MC31.03.2007
GR08.06.2007
PT07.08.2007
Former [2009/33]AT07.03.2007
BE07.03.2007
CY07.03.2007
DK07.03.2007
FI07.03.2007
NL07.03.2007
IE12.03.2007
MC31.03.2007
GR08.06.2007
PT07.08.2007
Former [2008/19]AT07.03.2007
BE07.03.2007
DK07.03.2007
FI07.03.2007
NL07.03.2007
IE12.03.2007
MC31.03.2007
GR08.06.2007
PT07.08.2007
Former [2008/10]AT07.03.2007
BE07.03.2007
DK07.03.2007
FI07.03.2007
NL07.03.2007
IE12.03.2007
MC31.03.2007
PT07.08.2007
Former [2008/09]AT07.03.2007
BE07.03.2007
DK07.03.2007
FI07.03.2007
NL07.03.2007
MC31.03.2007
PT07.08.2007
Former [2008/08]AT07.03.2007
BE07.03.2007
DK07.03.2007
FI07.03.2007
NL07.03.2007
PT07.08.2007
Former [2007/48]AT07.03.2007
BE07.03.2007
FI07.03.2007
NL07.03.2007
PT07.08.2007
Former [2007/46]AT07.03.2007
FI07.03.2007
NL07.03.2007
Former [2007/40]FI07.03.2007
NL07.03.2007
Former [2007/36]FI07.03.2007
Cited inInternational search[PX]WO0022131  (ARENA PHARM INC [US], et al) [PX] 1-16 * SEQ ID NO: 9, 10 *;
 [PX]WO0026339  (SMITHKLINE BEECHAM CORP [US]) [PX] 1-16 * SEQ ID NO: 1-4;; claims 1-14 *;
 [PX]WO0031258  (ARENA PHARM INC [US], et al) [PX] 1-16 * SEQ ID NO: 9, 10 *;
 [PX]DE19930512  (BRUES MICHAEL [DE], et al) [PX] 1-16 * the whole document;; claims 1-16 *;
 [E]EP1094075  (PFIZER LTD [GB], et al) [E] 1-16 * SEQ ID NO: 1 & 2;; claims 1,9-14,28-35 *;
 [E]WO0136473  (UPJOHN CO [US], et al) [E] 1-16 * SEQ ID NO: 67, 68, 91-94;; claims 1-42 *;
 [E]WO0142288  (INCYTE GENOMICS INC [US], et al) [E] 1-16 * SEQ ID NO: 23 & 62;; claims 1-16 *;
 [X]  - EMBL, (19981023), URL: EBI, XP002183865 [X] 1-3 * Nucleotides: 111.300 to 113.600; Homo sapiens chromosome 11 *
 [X]  - J F MADDOX ET AL., "Lipoxin A4 Stable Analogs are potent Mimetics that stimulate human monocytes and THP-1 cells via a G-protein-coupled Lipoxin A4 Receptor", J BIOL CHEM, (19970314), vol. 272, no. 11, pages 6972 - 6978, XP002183863 [X] 14,15 * results, pages 6973-6974;; figure 1 *

DOI:   http://dx.doi.org/10.1074/jbc.272.49.30993
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.